Business description
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.
Management board & Supervisory board
| CEO |
| Guillaume Daniellot |
| Management board |
| Dr. Peter Hackel, Camila Finzi, Wolfgang Becker, Jason Forbes , Holger Haderer, Patrick Loh , Alastair Robertson, Sébastien Roche, Aurelio Sahagun, Rahma Samow, Matthias Schupp, Dr Christian Ullrich |
| Supervisory board |
| Petra Rumpf, Dr. Beat Lüthi, Dr. Thomas Straumann, Marco Gadola, Regula Wallimann, Xiaoqun Clever-Steg, Stefan Meister, Olivier Filliol, Regula Wallimann |
Company data
| Name: |
Straumann Holding AG |
| Address: |
Peter Merian-Weg 12,CH-4052 Basel |
| Phone: |
+41-61-965-1111 |
| Fax: |
+41-61-965-1101 |
| E-mail: |
info@straumann.com
|
| Internet: |
www.straumann.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12-31 |
| Free Float: |
57.90% |
| IPO date: |
1998-01-01 |
